260 related articles for article (PubMed ID: 23401450)
21. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
Thomas M
Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
[No Abstract] [Full Text] [Related]
22. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
Felip E; Stahel RA; Pavlidis N;
Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
[No Abstract] [Full Text] [Related]
23. Non-small cell lung cancer: issues in diagnosis, staging and treatment.
Harwood KV
Semin Oncol Nurs; 1987 Aug; 3(3):183-93. PubMed ID: 3039637
[No Abstract] [Full Text] [Related]
24. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
Besse B; Le Chevalier T
J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
[No Abstract] [Full Text] [Related]
25. [Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].
Bompas E; Freyer G; Trillet-Lenoir V
Bull Cancer; 1998 Feb; 85(2):125-7. PubMed ID: 9752328
[No Abstract] [Full Text] [Related]
26. [Combination assay of tumor markers in predicting the effectiveness of chemotherapy in non-small lung cancer].
Satoh H; Yano H; Suyama T; Hasegawa S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):127-9. PubMed ID: 1346084
[No Abstract] [Full Text] [Related]
27. [P27 expression and survival in NSCLC].
Hirabayashi H
Nihon Rinsho; 2002 May; 60 Suppl 5():263-6. PubMed ID: 12101669
[No Abstract] [Full Text] [Related]
28. Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer.
D'Angelillo RM; Trodella L; Ramella S
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):489-90. PubMed ID: 15354115
[No Abstract] [Full Text] [Related]
29. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
Van Schil PE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
[No Abstract] [Full Text] [Related]
30. The treatment of inoperable patients with non-small-cell lung cancer.
Feld R
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():19-24. PubMed ID: 7602831
[No Abstract] [Full Text] [Related]
31. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
Belani CP
Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
[No Abstract] [Full Text] [Related]
32. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
33. Update in non-small cell lung cancer.
Moore T; Ready N
Med Health R I; 2002 Jan; 85(1):7-9. PubMed ID: 11824158
[No Abstract] [Full Text] [Related]
34. Evaluation and treatment of patients with non-small cell lung cancer.
Carr LL; Finigan JH; Kern JA
Med Clin North Am; 2011 Nov; 95(6):1041-54. PubMed ID: 22032426
[TBL] [Abstract][Full Text] [Related]
35. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
36. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
[No Abstract] [Full Text] [Related]
37. Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer.
Vos CG; Dahele M; Dickhoff C; Senan S; Thunnissen E; Hartemink KJ
Acta Oncol; 2013 Apr; 52(3):676-8. PubMed ID: 23098694
[No Abstract] [Full Text] [Related]
38. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
39. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
40. [Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].
Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H; ;
Pneumologie; 2011 Aug; 65(8):e51-75. PubMed ID: 21830177
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
